New agent, eribulin, derived from marine sponge, increases survival among women with metastatic breast cancer

ALK inhibitor shows high response rate in patients with advanced NSCLC harboring a specific gene alteration

Tumour circulating cells

The use of monoclonal antibodies to treat mesothelioma

The role of genetic mutations in lung cancer

The use of targeted radiotherapy to treat lung cancer

Advances in the treatment of lung cancer

The future of lung cancer treatment

Lung cancer treatment: new drugs and possibilities

Personalised treatment for lung cancer

Asbestos related diseases

MicroRNAs as novel therapeutic targets